Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station? Altorki NK, Villena-Vargas J. J Thorac Cardiovasc Surg 2022 Oct 30:S0022-5223(22)01152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Altorki NK, Villena-Vargas J. Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station? J Thorac Cardiovasc Surg 2022 Oct 30:S0022-5223(22)01152.
PMID: 36402582